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Biology of high radiation doses 
K. Skladowski 
The Institute of Oncology – Maria Sklodowska-Curie Memorial 
Cancer Center in Gliwice 
 
In this introductory lecture of the Symposium, essential 
knowledge concerning biological mechanisms of post high-
radiation dose will be present. Emerging evidence suggests 
that distinct mechanisms of cell death, likely including a 
major contribution from vascular epithelial cell apoptosis 
(devascularizing effect), might play an important role in the 
success of SBRT in controlling tumors. Also “5Rs” of 
conventional fractionated RT will be discussed in aspect of 
SBRT, including new pathways of tumor clonogen 
repopulation, i.e. “phoenix rising”, as well as constructing 
SBRT cell survival curve attempts. However, studies taken 
toward maximizing this effect should also be designed with 
the cautionary awareness that tissue regenerative processes 
might also be triggered as a result.  
 
Stereotactic RT systems and techniques overview 
K. Ślosarek 
The Institute of Oncology – Maria Sklodowska-Curie Memorial 
Cancer Center, Gliwice 
 
The lecture provides an overview of the therapeutic devices 
dedicated for stereotactic radiotherapy and presents 
technical capabilities of those devices. An important part of 
the irradiation process is patient stabilization during 
therapeutic session. Delivering high doses in few fractions 
forces us to apply patient alignment verification with greater 
precision than in the "classic" fractionated irradiation. The 
patient preparation process for stereotactic RT, as well as 
the stabilization of the patient and his alignment, must be 
extremely precise. Computed tomography, magnetic 
resonance imaging, positron emission tomography and image 
fusion are fundamental first examinations on the basis of 
which irradiation volume and critical structures are defined. 
Calculation of the dose distribution using a variety of 
treatment planning systems dedicated to different 
therapeutic devices causes that the defined therapeutic 
doses are not identical. The lecture concerns physical and 
technical aspects of the stereotactic RT realization: patient 
immobilization methods, imaging studies dedicated for 
treatment planning, ensuring QA, irradiation techniques and 
treatment delivery. 
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 Aim of the study 
The aim of the study is to present a new technology 
stereotactic treatment of low advanced lung cancer. 
Methodology and Results 
Radiation therapy is the primary treatment method for lung 
cancer. It is used in all stages of the disease, both in non-
open cell (NSCLC) and open cell (DRP) form of this cancer. 
According to epidemiological studies in developed countries, 
61-76% of patients with NSCLC in need of a form of 
radiotherapy at some stage of their illness. In the early 
embodiments, the severity of the disease if the patient is not 
a candidate for surgical treatment is applicable stereotactic 
radiotherapy. A breakthrough in the treatment of lung cancer 
was the use of high doses of factional in a study conducted by 
Timmerman. In these studies using fractional doses of 20Gy 
to 60Gy total dose for tumors T1 and 22Gy for T2 tumors  also 
given three times, local control of patients after a 2-year 
follow-up was 95% - results comparable to the effects of 
surgery. 
To realize such a high-dose radiation therapy techniques used 
to help to reduce the duration of treatment, optimal dose 
limiting critical structures, and 4D CT planning 4D CT which 
allowed to minimize the irradiation area. With this optimized 
radiation therapy can be taken to introduce a new 
technology. To realize the lung stereotactic radiosurgery 
technique is recommended dynamic arc. It is a sophisticated 
form of IMRT techniques (volumetric modulated arc therapy 
VMAT). By using this technique, the dose is deposited during 
continuous rotation of the gantry. This principle is similar to 
that used in tomo therapy, with the difference that the VMAT 
may be implemented using a conventional accelerator, which 
greatly increases the availability of the method. As indicated 
tests, the use of VMAT allows a highly conformal plan, 
compared to coplanar and non-coplanar IMRT techniques. 
Doses are receiving organs are critical in this technique 
adequately controlled, even with the possibility of reducing 
the dose in the lung tissue. Not to be underestimated is the 
fact that a significant reduction in irradiation time, up to 
<70% of the time needed for the implementation of IMRT 
plan. 
An important element of the proper conduct of radiotherapy 
is to specify the correct dose. Determine the accuracy and 
correctness of the dose by computerized calculations is 
related to the analysis of the currently available algorithms 
for estimating the dose in the areas generally considered 
difficult in the calculation. Areas of such specifics are the 
low density tissue eg. lung tissue surrounded by the standard 
density (similar to the density of water). Currently, there are 
two main groups (types) algorithms: type A and the more 
advanced type B. For type A are currently used algorithms 
Pencil Beam Convolution Model (PBC), which showed a dose 
distributions for a much more homogeneous lung tissue 
surrounded targets than Monte Carlo simulations (MC) - Type 
B. High-dose inhomogeneity in conducting simulations, mainly 
due to the inclusion of quantum transport doses distributed 
(distributed component). Lower energy quanta scattered, 
causing occurrence of heterogeneity in the distribution of 
absorbed dose. MC algorithms are considered the gold 
standard in the calculation of the dose, but not in widespread 
use because of limited access. Taking into account the lateral 
dispersion of "dense" tissue surrounding the lung, it became 
possible only after the introduction into clinical practice 
algorithm AAA-type B, only then you can get reliable 
information about the absorbed doses in the tumor and lung. 
AAA algorithm is considered to be an appropriate alternative 
to the MC. AAA and PBC algorithms show the difference 
related primarily to low-dose inhomogeneity in the PTV. DVH 
curve PBC model indicated a more uniform distribution in the 
tumor, thereby not causing significant dose overruns beyond 
the IRCU recommendations. However, in the calculation of 
the AAA, DVH curve indicated a significant heterogeneity, 
there were large areas covered with a low dose, this meant 
that in order to get the reference dose should renormalize 
DVH curve obtained by calculations AAA, in such a way that 
the minimum and mean doses meet the conditions of 
therapeutic doses and that determined the appearance of a 
relative high dose in the tumor and accordingly affect the 
increase in the lung dose. For this reason, in many centers 
conducting high-dose radiotherapy in lung cancer dose 
assignment changed methodology, eg. with 3x 3x20Gy at 
18Gy.  
Conclusions: In technical terms, SBRT uses all the 
achievements of modern technology: planning based on PET-
CT, the use of immobilization systems, setting targets based 
on the 4D-CT, planning based on advanced algorithms, IMRT, 
arc technique, gating and accurate verification of patient 
positioning on therapeutic table, for example. CBCT. 
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